These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32698996)

  • 1. Changes in serum KL-6 levels during short-term strict antigen avoidance are associated with the prognosis of patients with fibrotic hypersensitivity pneumonitis caused by avian antigens.
    Hanzawa S; Tateishi T; Ishizuka M; Inoue Y; Honda T; Kawahara T; Tomita M; Miyazaki Y
    Respir Investig; 2020 Nov; 58(6):457-464. PubMed ID: 32698996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis.
    Ejima M; Okamoto T; Suzuki T; Miyazaki Y
    Respir Investig; 2022 May; 60(3):369-378. PubMed ID: 34998715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YKL-40 and KL-6 Levels in Serum and Sputum of Patients Diagnosed With Hypersensitivity Pneumonitis.
    Sánchez-Díez S; Munoz X; Ojanguren I; Romero-Mesones C; Espejo D; Villar A; Gómez-Olles S; Cruz MJ
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2414-2423. PubMed ID: 35788062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis.
    He J; Zhang J; Ren X
    Front Immunol; 2022; 13():1041098. PubMed ID: 36532009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
    Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
    Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase.
    Okuda R; Takemura T; Iwasawa T; Kaburaki S; Baba T; Hagiwara E; Ogura T
    Allergy Asthma Clin Immunol; 2022 Dec; 18(1):104. PubMed ID: 36494847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis.
    Adams TN; Batra K; Kypreos M; Glazer CS
    BMC Pulm Med; 2023 Jun; 23(1):224. PubMed ID: 37349780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis.
    Tsutsui T; Miyazaki Y; Okamoto T; Tateishi T; Furusawa H; Tsuchiya K; Fujie T; Tamaoka M; Sakashita H; Sumi Y; Inase N
    Respir Investig; 2015 Sep; 53(5):217-24. PubMed ID: 26344611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
    Mostafa AI; Salem AE; Ahmed HAM; Bayoumi AI; Halim RMA; Samie RMA
    Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):200-208. PubMed ID: 33840176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krebs von den Lungen-6 (KL-6) is a pathophysiological biomarker of early-stage acute hypersensitivity pneumonitis among pigeon fanciers.
    Ji Y; Bourke SJ; Spears M; Wain LV; Boyd G; Lynch PP; Cunningham M; Boyd K; Donnelly I; Kohno N; McSharry C
    Clin Exp Allergy; 2020 Dec; 50(12):1391-1399. PubMed ID: 32966647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and monitoring of hypersensitivity pneumonitis.
    Miyazaki Y; Tsutsui T; Inase N
    Expert Rev Clin Immunol; 2016 Sep; 12(9):953-62. PubMed ID: 27117830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
    d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E
    Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis.
    Moll SA; Wiertz IA; Vorselaars ADM; Ruven HJT; van Moorsel CHM; Grutters JC
    Lung; 2020 Apr; 198(2):385-393. PubMed ID: 31993739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity pneumonitis caused by Penicillium citrinum, not Enoki spores.
    Yoshikawa S; Tsushima K; Yasuo M; Fujimoto K; Kubo K; Kumagai T; Yamazaki Y
    Am J Ind Med; 2007 Dec; 50(12):1010-7. PubMed ID: 17979128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis.
    Takimoto T; Nakamura Y
    Diseases; 2022 Jun; 10(3):. PubMed ID: 35892730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of inhalation challenge test and serum immunoglobulin G test for bird-related fibrotic hypersensitivity pneumonitis.
    Okuda R; Hagiwara E; Baba T; Kitamura H; Komatsu S; Kaburaki S; Mikami Y; Takemura T; Ogura T
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):313-318. PubMed ID: 35779842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
    Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
    Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis.
    Nukui Y; Yamana T; Masuo M; Tateishi T; Kishino M; Tateishi U; Tomita M; Hasegawa T; Aritsu T; Miyazaki Y
    PLoS One; 2019; 14(8):e0220462. PubMed ID: 31369605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.